Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shambhavi Naik"'
Autor:
Shambhavi Naik, Aditya Ramanathan
Publikováno v:
Indian Public Policy Review. 3:59-76
There is no evidence to suggest that SARS-CoV-2 was a biological agent. However, the ensuing pandemic has driven home the potential dangers of weaponised biological material, especially pathogens. Heightening the concerns about bioweapons is the grow
Autor:
Piers Millett, Shambhavi NAIK, Geoffrey OTIM, Oksana PIVEN, Maria Mercedes ROCA, Bonginkosi SHOZI, Daiane Priscila SIMÃO-SILVA, Kostas VAVITSAS, Zhaochen WANG
Publikováno v:
SSRN Electronic Journal.
Autor:
Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai, Pranay Kotasthane
Publikováno v:
Indian Public Policy Review. 1:42-58
Issue: Nov-Dec 2020 Deploying COVID-19 vaccines once they are available is going to be an unprecedented administrative and logistical challenge. This paper proposes a plan to vaccinate 80% of India’s population by December 2021. We envision this pr
Publikováno v:
Journal of Cellular Biochemistry. 116:1371-1380
Notch signaling has been established as a key regulator of cell fate in development, differentiation, and homeostasis. In breast cancers, increased Notch1 and Notch4 activity have been implicated in tumor progression and, accumulation of the intracel
Publikováno v:
Journal of cellular biochemistry. 116(7)
Notch signaling has been established as a key regulator of cell fate in development, differentiation, and homeostasis. In breast cancers, increased Notch1 and Notch4 activity have been implicated in tumor progression and, accumulation of the intracel
Autor:
Gerald M. Cohen, Marion MacFarlane, Jennifer M. Edwards, Rosemary A. Walker, Shambhavi Naik, Roshna Mistry, Davina Twiddy
Publikováno v:
Toxicology. 290:141-142
Autor:
Gerald M. Cohen, Marion MacFarlane, R. Mistry, Davina Twiddy, Rosemary A. Walker, Shambhavi Naik, Jennifer M. Edwards
Publikováno v:
Breast Cancer Research : BCR
Although the majority of tumour cell lines, including breast cancer cell lines, are sensitive to the death-inducing ligand and potential cancer biotherapeutic TNF-related apoptosis-inducing ligand (TRAIL), most primary tumours are TRAIL-resistant. Im